CellaVision: Setting priorities through double materiality
Type: Company & asset support
Timeline: Since 2024 (ongoing)
About CellaVision: CellaVision is a Swedish medical technology company and a pioneer in digital cell morphology. They provide digital microscopy solutions, covering analyzers, instruments, reagents, and software and have leading-edge expertise in sample preparation, image analysis, artificial intelligence, and automated microscopy. The products replace manual laboratory work and secure effective workflows within and between hospitals worldwide.
Our work: CellaVision has been working with Raison Consulting since 2024 to identify its key sustainability priorities and streamline its reporting in line with evolving frameworks, customer and investor requirements.
Our contribution:
- Delivered Cellavision’s first Double Materiality Assessment in line with the ESRS standards
- Ongoing strategic advisory on Group-wide priorities, internal governance and relevant reporting frameworks to align with investor and customer expectations
“
Raison provided invaluable support in conducting our Double Materiality Assessment and gap assessment with exceptional professionalism. Their methodology, documentation, and structured approach, as well as their clear and knowledgeable communication, were outstanding. Additionally, our audit committee has highlighted that the presentation of the DMA results, gap assessment, and recommended roadmap was among the best they have seen.”
Magnus Blixt
Chief Financial Officer (CFO), CellaVision